Susan Hill
FounderChief Executive Officer at Mestag Therapeutics
Cambridge, England, United Kingdom
FoundedMestag Therapeutics
Chief Executive Officer at Mestag Therapeutics
Intro paths
→
In turn, Susan can intro founders to Mestag Therapeutics's investors below.
Mestag Therapeutics's investors · 5
Co-founders at Mestag Therapeutics
MB
Michael B. BrennerFounder
CB
Chris BuckleyFounder
MC
Mark ColesFounder
SR
Soumya RaychaudhuriFounder
DA
David A. TuvesonFounder
Experience
- Mestag TherapeuticsChief Executive Officer, Co-Founder & Board Membercurrent2020 — presentCambridge
- Biotech CEO SisterhoodMembercurrent2022 — present
- SV Health InvestorsVenture Partnercurrent2020 — presentLondon
- Gyroscope Therapeutics, acquired by Novartis for $1.5bnChief Business Officer2019London UK / Philadelphia US
- Orbit Biomedical, Inc., acquired by Gyroscope 2019Chief Executive Officer2017 — 2019Philadelphia US / London UK
- Clipper BiotechFounder & Principal2015 — 2018Geneva, New York, London
- Spur TherapeuticsChief Business Officer (Freeline Therapeutics, now Spur Therapeutics)2016 — 2017London
- Lysogene TherapeuticsVP Business Development2015 — 2016Paris
- Alexion Pharmaceuticals, Inc.Senior Director, Global Business & Corporate Development2013 — 2015Geneva
- Merck SeronoHead of Global Portfolio Management, Fertility, Endocrinology & General Medicine2013Geneva
- Merck SeronoHead of Global Business Development, Neurodegenerative & Autoimmune Diseases2010 — 2013
- Merck HealthcareHead of Global Business Development, Fertility & Endocrinology2008 — 2010
- Merck HealthcareDirector Global Business Development2005 — 2008
- Aberdeen Asset ManagementWhite Rose Seedcorn Fund2002 — 2005
- KPMG Corporate FinanceHealthcare & Consumer Markets1999 — 2002
Skills & more
Start-upsMergersPharmaceutical IndustryBiotechnologyOncologyDrug DiscoveryMergers & AcquisitionsLicensingDrug DevelopmentCommercializationBusiness DevelopmentClinical Trials
+12 more
HealthcareBiopharmaceuticalsEndocrinologyEmerging MarketsLifesciencesClinical DevelopmentCross-functional Team LeadershipStrategyPortfolio ManagementLife SciencesTechnology TransferInvestmentsLanguages English · French
- Member of LifeScience ORG — LifeScience ORG
- previously Fellow of the Securities Institute — Securities Institute, UK
From Susan's professional profile.
Frequently asked questions
- Who is Susan Hill?
- Founder & Chief Executive Officer at Mestag Therapeutics
- Where does Susan Hill work?
- Susan Hill is Chief Executive Officer of Mestag Therapeutics.
- What companies did Susan Hill found?
- Susan Hill founded Mestag Therapeutics.
- Where did Susan Hill go to school?
- Susan Hill studied at IMD (Strategies for Leadership Program); University of Cambridge (Doctor of Philosophy (PhD), Molecular Biology & Diagnostics); University of Cambridge (Master of Arts (MA), Natural Sciences (focus on Molecular Biology)).
Are you in our directory? — or find your own page and tap it there to see your paths to every investor.
Founder mafias
University of Cambridge mafia586
Also came through, then founded or led a company.
Stewart ButterfieldMPhilFounded Flickr +1Demis HassabisBAFounded Google Deepmind +2C. Giovanni TraversoMBFounded Teal Bio +4Immad AkhundMaster of Arts (M.A.)Founded Mercury Technologies, Inc. +3Inaki BerenguerPhDFounded InfiniteWatch +2Harish AgarwalMaster of Philosophy - MPhilFounded Nori +2
+ 579 more
IMD mafia52
Also came through, then founded or led a company.
Veronica Gambillara FonckMaster of Business Administration - MBAFounded LimmaTech Biologics +1Oern R. StugeMBAFounded Impulse Dynamics +1Galina AntovaMaster of Business Administration - MBAFounded Claroty +1Heatherm HuangExecutive Education ProgramFounded RewardMe +1Oliver ClasenPEDFounded BIT CapitalOlivier LaplaceMaster of Business Administration (MBA)Founded Founders Pledge
+ 45 more
SV Health Investors mafia4
Also came through, then founded or led a company.
Mestag Therapeutics mafia3
Also came through, then founded or led a company.
Mestag mafia2
Also came through, then founded or led a company.
Same school
Also attended IMD257
Karthik ChakkarapaniInvestor at Foundation CapitalKulpreet SinghOperating Advisor at OpenOceanMusaad AlkadiSr. Principal at Graphene VenturesGrant AllenFounding GP, Schneider Electric Ventures at Giant Ventures Global LlpFredric PetitPartner, Head of Materials & Packaging at Emerald Technology Ventures AgMichael ZehnderHead of Digital Technology & Intelligence at Emerald Technology Ventures Ag
+ 251 more
Also attended University of Cambridge1,388
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosFounder and Managing Partner of VerdictGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
.png)
+ 1,382 more
Shared employers
Also worked at Mestag Therapeutics4
Also worked at Biotech CEO Sisterhood9
Shahid NimjeeCo-founder, Chief Scientific Officer and Stroke Clinical Lead at Basking BiosciencesYael WeissExecutive Officer, Director at Mahzi TherapeuticsJo VarshneyFounder at VeriSIM LifeSheila Gujrathi, MDFounder at Gossamer BioSandra DunnFounder at Phoenix Molecular DesignsCaitlyn KrebsCo-founder + CEO at NaluBio, Inc.
+ 3 more
Also worked at Spur Therapeutics1
Also worked at Alexion Pharmaceuticals, Inc.11
Abbie CelnikerInvestor at Third Rock VenturesSeung Hyun Moon, MD, MPAVenture Partner at Adelphi Ventures Management, LlcJustin WilliamsPrincipal at Seae VenturesRomesh SubramanianVenture Partner at Scion Life SciencesChristina BroomesCommercial Advisor at 2Flo VenturesJohn ReyndersChief Data Scientist & Venture Partner at Iaso Ventures
+ 5 more